Levosimendan and Global Longitudinal Strain Assessment in Sepsis (GLASSES 1): a study protocol for an observational study
Introduction Cardiogenic shock is a condition of low cardiac output that represents the end stage of a progressive deterioration of cardiac function. The main cause is ischaemic heart disease, but there are several non-ischaemic causes, including sepsis. The use of levosimendan in cardiogenic shock...
Saved in:
| Main Authors: | Iacopo Cappellini, Alessandra Melai, Lucia Zamidei, Maddalena Parise, Simone Cipani, Guglielmo Consales |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMJ Publishing Group
2020-09-01
|
| Series: | BMJ Open |
| Online Access: | https://bmjopen.bmj.com/content/10/9/e037188.full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Levosimendan Hemodynamic Effects Depending on the Outcome of Sepsis
by: I. N. Tyurin, et al.
Published: (2022-08-01) -
Levosimendan for sepsis-induced myocardial dysfunction: friend or foe?
by: Xinxin Du, et al.
Published: (2025-01-01) -
The Anti-Inflammatory Potential of Levosimendan in Sepsis: An Experimental Study Using a LPS-Induced Rat Model
by: Elif Dedeler Ertanıdır, et al.
Published: (2025-06-01) -
Bibliometric analysis of levosimendan
by: Xian-Shu Zhao, et al.
Published: (2025-02-01) -
Use of Levosimendan in Cardiac Anesthesiology
by: L. A. Krichevsky, et al.
Published: (2011-08-01)